Probing small molecule-protein interactions: A new perspective for functional proteomics

Journal of Proteomics

Volumn 75, Issue 1, 2011, Pages 100-115

  Lenz, Thomas ^a   Fischer, Jenny J ^a   Dreger, Mathias ^a  

^a Caprotec Bioanalytics GmbH   (Germany)

Author keywords

Activity based protein profiling; Affinity pulldown; Capture Compounds; Chemical proteomics; Mass spectrometry

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; CATECHOL METHYLTRANSFERASE INHIBITOR; CYCLIC AMP; CYCLIC GMP; ENTACAPONE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN; PROTEIN PHOSPHATASE METHYLESTERASE 1 INHIBITOR; TOLCAPONE; UNCLASSIFIED DRUG;

BINDING SITE; CAPTURE COMPOUND MASS SPECTROMETRY; CATALYSIS; FUNCTIONAL PROTEOMICS; HUMAN; LIQUID CHROMATOGRAPHY; LIVER TOXICITY; MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR PROBE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; ANIMAL; CHEMISTRY; GENE EXPRESSION PROFILING; METABOLISM; METHODOLOGY; MOLECULAR LIBRARY;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; MASS SPECTROMETRY; PROTEINS; PROTEOMICS; SMALL MOLECULE LIBRARIES;

EID: 84855360379     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.07.017     Document Type: Review

References (133)

1. Dreger M. Emerging strategies in mass-spectrometry based proteomics. Eur J Biochem 2003, 270:569.
2. Mann M., Ong S.E., Gronborg M., Steen H., et al. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 2002, 20:261-268.
3. Dreger M. Subcellular proteomics. Mass Spectrom Rev 2003, 22:27-56.
4. Bauer A., Kuster B. Affinity purification-mass spectrometry. Powerful tools for the characterization of protein complexes. Eur J Biochem 2003, 270:570-578.
5. Kruse U., Bantscheff M., Drewes G., Hopf C. Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. Mol Cell Proteomics 2008, 7:1887-1901.
6. Ovaa H., van Leeuwen F. Chemical biology approaches to probe the proteome. Chembiochem 2008, 9:2913-2919.
7. Uttamchandani M., Yao S.Q. The expanding world of small molecule microarrays. Methods Mol Biol 2010, 669:1-15.
8. Uttamchandani M., Lu C.H., Yao S.Q. Next generation chemical proteomic tools for rapid enzyme profiling. Acc Chem Res 2009, 42:1183-1192.
9. Kalesh K.A., Shi H., Ge J., Yao S.Q. The use of click chemistry in the emerging field of catalomics. Org Biomol Chem 2010, 8:1749-1762.
10. Dalhoff C., Lukinavicius G., Klimasauskas S., Weinhold E. Direct transfer of extended groups from synthetic cofactors by DNA methyltransferases. Nat Chem Biol 2006, 2:31-32.
11. Binda O., Boyce M., Rush J.S., Palaniappan K.K., et al. A chemical method for labeling lysine methyltransferase substrates. Chembiochem 2011, 12:330-334.
12. Martin B.R., Cravatt B.F. Large-scale profiling of protein palmitoylation in mammalian cells. Nat Methods 2009, 6:135-138.
13. Yang Y.Y., Ascano J.M., Hang H.C. Bioorthogonal chemical reporters for monitoring protein acetylation. J Am Chem Soc 2010, 132:3640-3641.
14. Prescher J.A., Dube D.H., Bertozzi C.R. Chemical remodelling of cell surfaces in living animals. Nature 2004, 430:873-877.
15. Chi Y., Welcker M., Hizli A.A., Posakony J.J., et al. Identification of CDK2 substrates in human cell lysates. Genome Biol 2008, 9:R149.
16. Lee S.E., Elphick L.M., Kramer H.B., Jones A.M., et al. The chemoselective one-step alkylation and isolation of thiophosphorylated Cdk2 substrates in the presence of native cysteine. Chembiochem 2011, [Electronic publication ahead of print].
17. DeGraw A.J., Palsuledesai C., Ochocki J.D., Dozier J.K., et al. Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation. Chem Biol Drug Des 2010, 76:460-471.
18. Chan L.N., Hart C., Guo L., Nyberg T., et al. A novel approach to tag and identify geranylgeranylated proteins. Electrophoresis 2009, 30:3598-3606.
19. Tate E.W. Recent advances in chemical proteomics: exploring the post-translational proteome. J Chem Biol 2008, 1:17-26.
20. Sletten E.M., Bertozzi C.R. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl 2009, 48:6974-6998.
21. Prescher J.A., Bertozzi C.R. Chemistry in living systems. Nat Chem Biol 2005, 1:13-21.
22. Keppler O.T., Horstkorte R., Pawlita M., Schmidt C., Reutter W. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 2001, 11:11R-18R.
23. Vila A., Tallman K.A., Jacobs A.T., Liebler D.C., et al. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem Res Toxicol 2008, 21:432-444.
24. Cuatrecasas P. Affinity chromatography. Annu Rev Biochem 1971, 40:259-278.
25. Bayley H., Knowles J.R. Photoaffinity labeling. Methods Enzymol 1977, 46:69-114.
26. Neurath H., Walsh K.A., Winter W.P. Evolution of structure and function of proteases. Science 1967, 158:1638-1644.
27. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
28. Cravatt B.F., Simon G.M., Yates J.R. The biological impact of mass-spectrometry-based proteomics. Nature 2007, 450:991-1000.
29. Verhelst S.H., Bogyo M. Chemical proteomics applied to target identification and drug discovery. Biotechniques 2005, 38:175-177.
30. Fonovic M., Verhelst S.H., Sorum M.T., Bogyo M. Proteomics evaluation of chemically cleavable activity-based probes. Mol Cell Proteomics 2007, 6:1761-1770.
31. Rix U., Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat Chem Biol 2009, 5:616-624.
32. Jeffery D.A., Bogyo M. Chemical proteomics and its application to drug discovery. Curr Opin Biotechnol 2003, 14:87-95.
33. Liu Y., Patricelli M.P., Cravatt B.F. Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci U S A 1999, 96:14694-14699.
34. Cravatt B.F., Sorensen E.J. Chemical strategies for the global analysis of protein function. Curr Opin Chem Biol 2000, 4:663-668.
35. Koster H., Little D.P., Luan P., Muller R., et al. Capture compound mass spectrometry: a technology for the investigation of small molecule protein interactions. Assay Drug Dev Technol 2007, 5:381-390.
36. Bantscheff M., Eberhard D., Abraham Y., Bastuck S., et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol 2007, 25:1035-1044.
37. Rix U., Hantschel O., Durnberger G., Remsing Rix L.L., et al. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 2007, 110:4055-4063.
38. Lenz T., Poot P., Grabner O., Glinski M., et al. Profiling of methyltransferases and other S-adenosyl-L-homocysteine-binding proteins by Capture Compound Mass Spectrometry (CCMS). J Vis Exp 2010, [Electronic publication ahead of print].
39. Verdoes M., Florea B.I., Menendez-Benito V., Maynard C.J., et al. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol 2006, 13:1217-1226.
40. Ovaa H., van Swieten P.F., Kessler B.M., Leeuwenburgh M.A., et al. Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy. Angew Chem Int Ed Engl 2003, 42:3626-3629.
41. Speers A.E., Adam G.C., Cravatt B.F. Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3+2] cycloaddition. J Am Chem Soc 2003, 125:4686-4687.
42. Salisbury C.M., Cravatt B.F. Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc Natl Acad Sci U S A 2007, 104:1171-1176.
43. Best M.D. Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry 2009, 48:6571-6584.
44. Kolb H.C., Sharpless K.B. The growing impact of click chemistry on drug discovery. Drug Discov Today 2003, 8:1128-1137.
45. Karaman M.W., Herrgard S., Treiber D.K., Gallant P., et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008, 26:127-132.
46. Luo Y., Blex C., Baessler O., Glinski M., et al. The cAMP capture compound mass spectrometry as a novel tool for targeting cAMP-binding proteins: from protein kinase A to potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channels. Mol Cell Proteomics 2009, 8:2843-2856.
47. Rotili D., Altun M., Kawamura A., Wolf A., et al. A photoreactive small-molecule probe for 2-oxoglutarate oxygenases. Chem Biol 2011, 18:642-654.
48. Jessani N., Humphrey M., McDonald W.H., Niessen S., et al. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci U S A 2004, 101:13756-13761.
49. Morak M., Schmidinger H., Krempl P., Rechberger G., et al. Differential activity-based gel electrophoresis for comparative analysis of lipolytic and esterolytic activities. J Lipid Res 2009, 50:1281-1292.
50. Bantscheff M., Hopf C., Kruse U., Drewes G. Proteomics-based strategies in kinase drug discovery. Ernst Schering Found Symp Proc 2007, 1-28.
51. Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., et al. Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 2009, 8:1751-1764.
52. Wissing J., Jansch L., Nimtz M., Dieterich G., et al. Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Mol Cell Proteomics 2007, 6:537-547.
53. Daub H., Olsen J.V., Bairlein M., Gnad F., et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 2008, 31:438-448.
54. Bantscheff M., Hopf C., Savitski M.M., Dittmann A., et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol 2011, 29:255-265.
55. Scholten A., Poh M.K., van Veen T.A., van Breukelen B., et al. Analysis of the cGMP/cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP. J Proteome Res 2006, 5:1435-1447.
56. Scholten A., van Veen T.A., Vos M.A., Heck A.J. Diversity of cAMP-dependent protein kinase isoforms and their anchoring proteins in mouse ventricular tissue. J Proteome Res 2007, 6:1705-1717.
57. Visser N.F., Scholten A., van den Heuvel R.H., Heck A.J. Surface-plasmon-resonance-based chemical proteomics: efficient specific extraction and semiquantitative identification of cyclic nucleotide-binding proteins from cellular lysates by using a combination of surface plasmon resonance, sequential elution and liquid chromatography-tandem mass spectrometry. Chembiochem 2007, 8:298-305.
58. Aye T.T., Mohammed S., van den Toorn H.W., van Veen T.A., et al. Selectivity in enrichment of cAMP-dependent protein kinase regulatory subunits type I and type II and their interactors using modified cAMP affinity resins. Mol Cell Proteomics 2009, 8:1016-1028.
59. Kovanich D., van der Heyden M.A., Aye T.T., van Veen T.A., et al. Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase. Chembiochem 2010, 11:963-971.
60. Hanke S.E., Bertinetti D., Badel A., Schweinsberg S., et al. Cyclic nucleotides as affinity tools: phosphorothioate cAMP analogues address specific PKA subproteomes. Nat Biotechnol 2011, 28:294-301.
61. Chan D.W., Wang Y., Wu M., Wong J., et al. Unbiased proteomic screen for binding proteins to modified lysines on histone H3. Proteomics 2009, 9:2343-2354.
62. Teranishi Y., Hur J.Y., Welander H., Franberg J., et al. Affinity pulldown of gamma-secretase and associated proteins from human and rat brain. J Cell Mol Med 2010, 14:2675-2686.
63. Dejardin J., Kingston R.E. Purification of proteins associated with specific genomic Loci. Cell 2009, 136:175-186.
64. Bantscheff M., Scholten A., Heck A.J. Revealing promiscuous drug-target interactions by chemical proteomics. Drug Discov Today 2009, 14:1021-1029.
65. Barglow K.T., Cravatt B.F. Activity-based protein profiling for the functional annotation of enzymes. Nat Methods 2007, 4:822-827.
66. Fonovic M., Bogyo M. Activity-based probes as a tool for functional proteomic analysis of proteases. Expert Rev Proteomics 2008, 5:721-730.
67. Jessani N., Niessen S., Wei B.Q., Nicolau M., et al. A streamlined platform for high-content functional proteomics of primary human specimens. Nat Methods 2005, 2:691-697.
68. Jessani N., Liu Y., Humphrey M., Cravatt B.F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci U S A 2002, 99:10335-10340.
69. Chiang K.P., Niessen S., Saghatelian A., Cravatt B.F. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem Biol 2006, 13:1041-1050.
70. Madsen M.A., Deryugina E.I., Niessen S., Cravatt B.F., Quigley J.P. Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation. J Biol Chem 2006, 281:15997-16005.
71. Gillet L.C., Namoto K., Ruchti A., Hoving S., et al. In-cell selectivity profiling of serine protease inhibitors by activity-based proteomics. Mol Cell Proteomics 2008, 7:1241-1253.
72. Greenbaum D., Medzihradszky K.F., Burlingame A., Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem Biol 2000, 7:569-581.
73. Kato D., Boatright K.M., Berger A.B., Nazif T., et al. Activity-based probes that target diverse cysteine protease families. Nat Chem Biol 2005, 1:33-38.
74. Paulick M.G., Bogyo M. Application of activity-based probes to the study of enzymes involved in cancer progression. Curr Opin Genet Dev 2008, 18:97-106.
75. Vasiljeva O., Papazoglou A., Kruger A., Brodoefel H., et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 2006, 66:5242-5250.
76. Furman L.M., Maaty W.S., Petersen L.K., Ettayebi K., et al. Cysteine protease activation and apoptosis in Murine norovirus infection. Virol J 2009, 6:139.
77. Puri A.W., Bogyo M. Using small molecules to dissect mechanisms of microbial pathogenesis. ACS Chem Biol 2009, 4:603-616.
78. Birner-Gruenberger R., Susani-Etzerodt H., Kollroser M., Rechberger G.N., Hermetter A. Lipolytic and esterolytic activity-based profiling of murine liver. Proteomics 2008, 8:3645-3656.
79. Schicher M., Morak M., Birner-Gruenberger R., Kayer H., et al. Functional proteomic analysis of lipases and esterases in cultured human adipocytes. J Proteome Res 2010, 9:6334-6344.
80. Bogyo M., McMaster J.S., Gaczynska M., Tortorella D., et al. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc Natl Acad Sci U S A 1997, 94:6629-6634.
81. Verdoes M., Willems L.I., van der Linden W.A., Duivenvoorden B.A., et al. A panel of subunit-selective activity-based proteasome probes. Org Biomol Chem 2010, 8:2719-2727.
82. Willems L.I., Verdoes M., Florea B.I., van der Marel G.A., Overkleeft H.S. Two-step labeling of endogenous enzymatic activities by Diels-Alder ligation. Chembiochem 2010, 11:1769-1781.
83. Florea B.I., Verdoes M., Li N., van der Linden W.A., et al. Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chem Biol 2010, 17:795-801.
84. Love K.R., Catic A., Schlieker C., Ploegh H.L. Mechanisms, biology and inhibitors of deubiquitinating enzymes. Nat Chem Biol 2007, 3:697-705.
85. Borodovsky A., Kessler B.M., Casagrande R., Overkleeft H.S., et al. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J 2001, 20:5187-5196.
86. Borodovsky A., Ovaa H., Kolli N., Gan-Erdene T., et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol 2002, 9:1149-1159.
87. Ovaa H., Kessler B.M., Rolen U., Galardy P.J., et al. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc Natl Acad Sci U S A 2004, 101:2253-2258.
88. Patricelli M.P., Szardenings A.K., Liyanage M., Nomanbhoy T.K., et al. Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 2007, 46:350-358.
89. Liu K., Kalesh K.A., Ong L.B., Yao S.Q. An improved mechanism-based cross-linker for multiplexed kinase detection and inhibition in a complex proteome. Chembiochem 2008, 9:1883-1888.
90. Kalesh K.A., Tan L.P., Lu K., Gao L., et al. Peptide-based activity-based probes (ABPs) for target-specific profiling of protein tyrosine phosphatases (PTPs). Chem Commun (Camb) 2010, 46:589-591.
91. Kumar S., Zhou B., Liang F., Wang W.Q., et al. Activity-based probes for protein tyrosine phosphatases. Proc Natl Acad Sci U S A 2004, 101:7943-7948.
92. Tully S.E., Cravatt B.F. Activity-based probes that target functional subclasses of phospholipases in proteomes. J Am Chem Soc 2010, 132:3264-3265.
93. Hekmat O., Kim Y.W., Williams S.J., He S., Withers S.G. Active-site peptide "fingerprinting" of glycosidases in complex mixtures by mass spectrometry. Discovery of a novel retaining beta-1,4-glycanase in Cellulomonas fimi. J Biol Chem 2005, 280:35126-35135.
94. Williams S.J., Hekmat O., Withers S.G. Synthesis and testing of mechanism-based protein-profiling probes for retaining endo-glycosidases. Chembiochem 2006, 7:116-124.
95. Hekmat O., He S., Warren R.A., Withers S.G. A mechanism-based ICAT strategy for comparing relative expression and activity levels of glycosidases in biological systems. J Proteome Res 2008, 7:3282-3292.
96. Stubbs K.A., Scaffidi A., Debowski A.W., Mark B.L., et al. Synthesis and use of mechanism-based protein-profiling probes for retaining beta-D-glucosaminidases facilitate identification of Pseudomonas aeruginosa NagZ. J Am Chem Soc 2008, 130:327-335.
97. Wright A.T., Song J.D., Cravatt B.F. A suite of activity-based probes for human cytochrome P450 enzymes. J Am Chem Soc 2009, 131:10692-10700.
98. Wright A.T., Cravatt B.F. Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo. Chem Biol 2007, 14:1043-1051.
99. van Swieten P.F., Maehr R., van den Nieuwendijk A.M., Kessler B.M., et al. Development of an isotope-coded activity-based probe for the quantitative profiling of cysteine proteases. Bioorg Med Chem Lett 2004, 14:3131-3134.
100. Everley P.A., Gartner C.A., Haas W., Saghatelian A., et al. Assessing enzyme activities using stable isotope labeling and mass spectrometry. Mol Cell Proteomics 2007, 6:1771-1777.
101. Robinette D., Neamati N., Tomer K.B., Borchers C.H. Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics. Expert Rev Proteomics 2006, 3:399-408.
102. Fischer JJ, Dalhoff C, Schrey AK, Graebner Nee Baessler OY, et al. Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS). J Proteomics in press.
103. Fischer J.J., Graebner Baessler O.Y., Dalhoff C., Michaelis S., et al. Comprehensive identification of staurosporine-binding kinases in the hepatocyte cell line HepG2 using Capture Compound Mass Spectrometry (CCMS). J Proteome Res 2010, 9:806-817.
104. Luo Y., Fischer J.J., Baessler O.Y., Schrey A.K., et al. GDP-capture compound-a novel tool for the profiling of GTPases in pro- and eukaryotes by capture compound mass spectrometry (CCMS). J Proteomics 2010, 73:815-819.
105. Dalhoff C., Huben M., Lenz T., Poot P., et al. Synthesis of S-adenosyl-L-homocysteine capture compounds for selective photoinduced isolation of methyltransferases. Chembiochem 2010, 11:256-265.
106. Wirsing L., Naumann K., Vogt T. Arabidopsis methyltransferase fingerprints by affinity-based protein profiling. Anal Biochem 2011, 408:220-225.
107. Schrimpf S.P., Meskenaite V., Brunner E., Rutishauser D., et al. Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics 2005, 5:2531-2541.
108. Trinidad J.C., Thalhammer A., Specht C.G., Lynn A.J., et al. Quantitative analysis of synaptic phosphorylation and protein expression. Mol Cell Proteomics 2008, 7:684-696.
109. Rotili D., Altun M., Hamed R.B., Loenarz C., et al. Photoactivable peptides for identifying enzyme-substrate and protein-protein interactions. Chem Commun (Camb) 2011, 47:1488-1490.
110. Nakai R., Salisbury C.M., Rosen H., Cravatt B.F. Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study. Bioorg Med Chem 2009, 17:1101-1108.
111. Salisbury C.M., Cravatt B.F. Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes. J Am Chem Soc 2008, 130:2184-2194.
112. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
113. Nagase H., Enghild J.J., Suzuki K., Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 1990, 29:5783-5789.
114. Wyatt R.A., Keow J.Y., Harris N.D., Hache C.A., et al. The zebrafish embryo: a powerful model system for investigating matrix remodeling. Zebrafish 2009, 6:347-354.
115. Tantama M., Lin W.C., Licht S. An activity-based protein profiling probe for the nicotinic acetylcholine receptor. J Am Chem Soc 2008, 130:15766-15767.
116. Li X., Cao J.H., Li Y., Rondard P., et al. Activity-based probe for specific photoaffinity labeling gamma-aminobutyric acid B (GABAB) receptors on living cells: design, synthesis, and biological evaluation. J Med Chem 2008, 51:3057-3060.
117. Fischer J.J., Michaelis S., Schrey A.K., Graebner O.G., et al. Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs. Toxicol Sci 2010, 113:243-253.
118. Sato S., Murata A., Shirakawa T., Uesugi M. Biochemical target isolation for novices: affinity-based strategies. Chem Biol 2010, 17:616-623.
119. Cheng K.W., Wong C.C., Wang M., He Q.Y., Chen F. Identification and characterization of molecular targets of natural products by mass spectrometry. Mass Spectrom Rev 2010, 29:126-155.
120. Harding M.W., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989, 341:758-760.
121. Margolin A.A., Ong S.E., Schenone M., Gould R., et al. Empirical Bayes analysis of quantitative proteomics experiments. PLoS One 2009, 4:e7454.
122. Ong S.E., Schenone M., Margolin A.A., Li X., et al. Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci U S A 2009, 106:4617-4622.
123. Rix U., Remsing Rix L.L., Terker A.S., Fernbach N.V., et al. A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. Leukemia 2010, 24:44-50.
124. He G., Luo W., Li P., Remmers C., et al. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 2010, 467:95-98.
125. Netzer W.J., Dou F., Cai D., Veach D., et al. Gleevec inhibits beta-amyloid production but not Notch cleavage. Proc Natl Acad Sci U S A 2003, 100:12444-12449.
126. Staub I., Sieber S.A. Beta-lactam probes as selective chemical-proteomic tools for the identification and functional characterization of resistance associated enzymes in MRSA. J Am Chem Soc 2009, 131:6271-6276.
127. Bachovchin D.A., Brown S.J., Rosen H., Cravatt B.F. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Nat Biotechnol 2009, 27:387-394.
128. Bachovchin D.A., Mohr J.T., Speers A.E., Wang C., et al. Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors. Proc Natl Acad Sci U S A 2011, 108:6811-6816.
129. Ahn K., Johnson D.S., Mileni M., Beidler D., et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 2009, 16:411-420.
130. Kroll F., Dreger M. Are meaningful predictions of toxicological outcomes in clinical trials based on in vitro diagnostics of preclinical drug candidates possible?. Future Med Chem 2010, 2:1613-1617.
131. Haasio K. Toxicology and safety of COMT inhibitors. Int Rev Neurobiol 2010, 95:163-189.
132. Haasio K., Koponen A., Penttila K.E., Nissinen E. Effects of entacapone and tolcapone on mitochondrial membrane potential. Eur J Pharmacol 2002, 453:21-26.
133. Haasio K., Nissinen E., Sopanen L., Heinonen E.H. Different toxicological profile of two COMT inhibitors in vivo: the role of uncoupling effects. J Neural Transm 2002, 109:1391-1401.